SL Science Holding Limited (SLBT) Stock
SL Science stock price chart
SLBT stock quote & key statistics
SL Science annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $2.2M | -$3.8M | — |
| FY2024 | $3.4M | -$1.2M | — |
| FY2023 | $878,971 | $399,035 | — |
Fiscal year ending December 31. Source: company filings via EODHD.
About SL Science Holding Limited
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
SL Science stock FAQ
What is the SL Science stock ticker symbol?
SL Science Holding Limited trades on the NASDAQ under the ticker symbol SLBT.
What sector and industry is SL Science in?
SL Science Holding Limited is classified in the Healthcare sector, Biotechnology industry.
How many employees does SL Science have?
SL Science Holding Limited has about 14 full-time employees.
What were SL Science's revenue and earnings last fiscal year?
SL Science reported revenue of $2.2M and net income of -$3.8M in fiscal 2025. Revenue declined 34.7% from the prior year.
When did SL Science go public?
SL Science stock began trading on June 15, 2026.
Biotechnology stocks
All Healthcare stocks →- ACADACADIA Pharmaceuticals
- ALNYAlnylam
- ARWRArrowhead Pharmaceuticals
- ASNDAscendis Pharma A/S
- BMRNBioMarin Pharmaceutical
- CAICaris Life Sciences
- CORTCorcept Therapeutics
- EXELExelixis
- FTREFortrea
- HALOHalozyme Therapeutics
- HRMYHarmony Biosciences
- INCYIncyte
- IONSIonis Pharmaceuticals
- JAZZJazz Pharmaceuticals
- MDGLMadrigal Pharmaceuticals
- MRNAModerna
- NVAXNovavax
- PTCTPTC Therapeutics
- RAREUltragenyx Pharmaceutical
- REGNRegeneron
- RPRXRoyalty Pharma
- SRPTSarepta Therapeutics
- TECHBio-Techne
- VRTXVertex